chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood potassium decreased, Dysphagia, Electrocardiogram normal, Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: Within 5 minutes of the shot, I started to have difficulty swallowing. I notified the staff at the clinic, They put me in a separate room where I took 50mg Benadryl. I continued having difficulty swallowing along with tingling in tongue and lips. I then decided to give myself an Epipen 0.3mg shot. I had this with me because I had a severe allergic reaction in January to Pfizer COVID 19 vaccine. 911 was called. In the ambulance, IV Benadryl and Solu-Medrol was administered. My face was starting to itch on the way to hospital even after IV medication administered.  I was monitored for 2 hours in hospital. I was also given normal saline IV in the hospital. I was discharged with Pepcid 20mg daily for 4 days and Prednisone 50mg daily for 3 days. I consistently had to take Benadryl 50mg for three days to keep itching and swelling at bay.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Paraesthesia oral, Pruritus, Swelling, White blood cell count
Clinical narrative: Within 5 minutes of the shot, I started to have difficulty swallowing. I notified the staff at the clinic, They put me in a separate room where I took 50mg Benadryl. I continued having difficulty swallowing along with tingling in tongue and lips. I then decided to give myself an Epipen 0.3mg shot. I had this with me because I had a severe allergic reaction in January to Pfizer COVID 19 vaccine. 911 was called. In the ambulance, IV Benadryl and Solu-Medrol was administered. My face was starting to itch on the way to hospital even after IV medication administered.  I was monitored for 2 hours in hospital. I was also given normal saline IV in the hospital. I was discharged with Pepcid 20mg daily for 4 days and Prednisone 50mg daily for 3 days. I consistently had to take Benadryl 50mg for three days to keep itching and swelling at bay.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Hypoaesthesia oral, Paraesthesia oral, Pharyngeal swelling, SARS-CoV-2 test
Clinical narrative: 1710 on 1/18 received the second Pfizer COVID-19 vaccination. 1740 developed chest tightness, wheezing, throat tightening, tongue tingling, lip tingling
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: 1710 on 1/18 received the second Pfizer COVID-19 vaccination. 1740 developed chest tightness, wheezing, throat tightening, tongue tingling, lip tingling
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Paraesthesia oral, Throat tightness, Wheezing
Clinical narrative: 1710 on 1/18 received the second Pfizer COVID-19 vaccination. 1740 developed chest tightness, wheezing, throat tightening, tongue tingling, lip tingling
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Heart rate increased, Heart rate irregular, Tremor
Clinical narrative: Pt reported racing heart, feeling hot and shakey. Vital signs WNL, monitored patient for an additonal 15 minutes. Pt reported heart rate felt normal, but still feeling shakey. Report called to the ER and patient transported via wheelchair to ER for e,valua
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Nervousness, Palpitations
Clinical narrative: Pt reported racing heart, feeling hot and shakey. Vital signs WNL, monitored patient for an additonal 15 minutes. Pt reported heart rate felt normal, but still feeling shakey. Report called to the ER and patient transported via wheelchair to ER for e,valua
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: My brother received the first dose of Moderna Covid 19 vaccine on Friday 2/5/21. He texted with friends at approximately 11 PM on 2/5/21 that he was feeling no side effects.  was found deceased in his home on Sunday 2/7/21. Because of his daily habits and failure to update a calendar in his home to Feb 6, we believe he died between 11 PM 2/5 and 10 AM 2/6/21 . His time of death as listed don his death certificate in time/date and discovery of his body.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Death
Clinical narrative: My brother received the first dose of Moderna Covid 19 vaccine on Friday 2/5/21. He texted with friends at approximately 11 PM on 2/5/21 that he was feeling no side effects.  was found deceased in his home on Sunday 2/7/21. Because of his daily habits and failure to update a calendar in his home to Feb 6, we believe he died between 11 PM 2/5 and 10 AM 2/6/21 . His time of death as listed don his death certificate in time/date and discovery of his body.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Impaired work ability, Lip swelling, Pruritus, Rash, Swelling face
Clinical narrative: awoke with swollen face and lips; awoke with swollen face and lips; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; full body aches; joint pain; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 36-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EM9810), via an unspecified route of administration administered in right arm on 05Feb2021 at 12:15 (at the age of 36 years-of-old) at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included (sertraline hydrochloride) ZOLOFT, (cyanocobalamin) VIT B12, (colecalciferol) VIT D3 and multivitamins. The patient previously received first dose of bnt162b2 in right arm on 15Jan2021 at single dose for COVID-19 immunisation. On 06Feb2021, the patient experienced full body aches, joint pain and fatigue. On 08Feb2021, the patient experienced itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash. On 09Feb2021, the patient had full body red, itchy rash and went to urgent care and received prescription for topical steroid. On 10Feb2021, the patient awoke with swollen face and lips. The swelling subsided within 1 hour of waking, but full body itchy, red rash persisted. The patient had very little relief from creams or medication. On 11Feb2021, the full body itchy, red rash persisted. The patient spoke to staff that administered the vaccine and was told to see additional care if rash is not resolved by Monday. On 12Feb2021, the rash has improved with the help of ibuprofen and time. Itchiness returns once ibuprofen wears off. The patient did not take any other vaccine in four weeks. The patient did not had COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events full body aches, joint pain and fatigue was recovered on 07Feb2021 and the event awoke with swollen face and lips recovered on 10Feb2021. The outcome was recovering for the rest of the events.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Lip swelling, Pain, Rash erythematous
Clinical narrative: awoke with swollen face and lips; awoke with swollen face and lips; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; full body aches; joint pain; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 36-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EM9810), via an unspecified route of administration administered in right arm on 05Feb2021 at 12:15 (at the age of 36 years-of-old) at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included (sertraline hydrochloride) ZOLOFT, (cyanocobalamin) VIT B12, (colecalciferol) VIT D3 and multivitamins. The patient previously received first dose of bnt162b2 in right arm on 15Jan2021 at single dose for COVID-19 immunisation. On 06Feb2021, the patient experienced full body aches, joint pain and fatigue. On 08Feb2021, the patient experienced itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash. On 09Feb2021, the patient had full body red, itchy rash and went to urgent care and received prescription for topical steroid. On 10Feb2021, the patient awoke with swollen face and lips. The swelling subsided within 1 hour of waking, but full body itchy, red rash persisted. The patient had very little relief from creams or medication. On 11Feb2021, the full body itchy, red rash persisted. The patient spoke to staff that administered the vaccine and was told to see additional care if rash is not resolved by Monday. On 12Feb2021, the rash has improved with the help of ibuprofen and time. Itchiness returns once ibuprofen wears off. The patient did not take any other vaccine in four weeks. The patient did not had COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events full body aches, joint pain and fatigue was recovered on 07Feb2021 and the event awoke with swollen face and lips recovered on 10Feb2021. The outcome was recovering for the rest of the events.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash pruritic, Swelling face
Clinical narrative: awoke with swollen face and lips; awoke with swollen face and lips; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; full body aches; joint pain; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 36-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EM9810), via an unspecified route of administration administered in right arm on 05Feb2021 at 12:15 (at the age of 36 years-of-old) at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included (sertraline hydrochloride) ZOLOFT, (cyanocobalamin) VIT B12, (colecalciferol) VIT D3 and multivitamins. The patient previously received first dose of bnt162b2 in right arm on 15Jan2021 at single dose for COVID-19 immunisation. On 06Feb2021, the patient experienced full body aches, joint pain and fatigue. On 08Feb2021, the patient experienced itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash. On 09Feb2021, the patient had full body red, itchy rash and went to urgent care and received prescription for topical steroid. On 10Feb2021, the patient awoke with swollen face and lips. The swelling subsided within 1 hour of waking, but full body itchy, red rash persisted. The patient had very little relief from creams or medication. On 11Feb2021, the full body itchy, red rash persisted. The patient spoke to staff that administered the vaccine and was told to see additional care if rash is not resolved by Monday. On 12Feb2021, the rash has improved with the help of ibuprofen and time. Itchiness returns once ibuprofen wears off. The patient did not take any other vaccine in four weeks. The patient did not had COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events full body aches, joint pain and fatigue was recovered on 07Feb2021 and the event awoke with swollen face and lips recovered on 10Feb2021. The outcome was recovering for the rest of the events.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Lethargy, Pain, Pruritus, Rash
Clinical narrative: awoke with swollen face and lips; awoke with swollen face and lips; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash; full body aches; joint pain; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 36-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EM9810), via an unspecified route of administration administered in right arm on 05Feb2021 at 12:15 (at the age of 36 years-of-old) at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included (sertraline hydrochloride) ZOLOFT, (cyanocobalamin) VIT B12, (colecalciferol) VIT D3 and multivitamins. The patient previously received first dose of bnt162b2 in right arm on 15Jan2021 at single dose for COVID-19 immunisation. On 06Feb2021, the patient experienced full body aches, joint pain and fatigue. On 08Feb2021, the patient experienced itchy, red rash began on arms and spread to torso and legs by evening/full body red, itchy rash. On 09Feb2021, the patient had full body red, itchy rash and went to urgent care and received prescription for topical steroid. On 10Feb2021, the patient awoke with swollen face and lips. The swelling subsided within 1 hour of waking, but full body itchy, red rash persisted. The patient had very little relief from creams or medication. On 11Feb2021, the full body itchy, red rash persisted. The patient spoke to staff that administered the vaccine and was told to see additional care if rash is not resolved by Monday. On 12Feb2021, the rash has improved with the help of ibuprofen and time. Itchiness returns once ibuprofen wears off. The patient did not take any other vaccine in four weeks. The patient did not had COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events full body aches, joint pain and fatigue was recovered on 07Feb2021 and the event awoke with swollen face and lips recovered on 10Feb2021. The outcome was recovering for the rest of the events.
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arterial disorder, Contusion, Death, Dysphagia, Haematoma
Clinical narrative: PATIENT HAD BRUISING AROUND INJECTION SITE OF 2ND VACCINE (LEFT DELTOID), BRUSING AND SWELLING PROGRESSED DOWN ARM AND HAND, PATIENT WAS SENT TO ER AND THEN HOSPITALIZED.  PATIENT THEN PASSED AWAY SHORTLY THEREAFTER IN THE HOSPITAL FROM MASSIVE BLOOD CLOTS AROUND EVERY LYMPH NODE IN THE BODY
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haemorrhage, Limb mass, Oedema peripheral, Peripheral swelling, Skin discolouration
Clinical narrative: PATIENT HAD BRUISING AROUND INJECTION SITE OF 2ND VACCINE (LEFT DELTOID), BRUSING AND SWELLING PROGRESSED DOWN ARM AND HAND, PATIENT WAS SENT TO ER AND THEN HOSPITALIZED.  PATIENT THEN PASSED AWAY SHORTLY THEREAFTER IN THE HOSPITAL FROM MASSIVE BLOOD CLOTS AROUND EVERY LYMPH NODE IN THE BODY
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Suture insertion, Thrombosis, Vein disorder
Clinical narrative: PATIENT HAD BRUISING AROUND INJECTION SITE OF 2ND VACCINE (LEFT DELTOID), BRUSING AND SWELLING PROGRESSED DOWN ARM AND HAND, PATIENT WAS SENT TO ER AND THEN HOSPITALIZED.  PATIENT THEN PASSED AWAY SHORTLY THEREAFTER IN THE HOSPITAL FROM MASSIVE BLOOD CLOTS AROUND EVERY LYMPH NODE IN THE BODY
Age: 95.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Injection site bruising, Peripheral swelling, Thrombosis
Clinical narrative: PATIENT HAD BRUISING AROUND INJECTION SITE OF 2ND VACCINE (LEFT DELTOID), BRUSING AND SWELLING PROGRESSED DOWN ARM AND HAND, PATIENT WAS SENT TO ER AND THEN HOSPITALIZED.  PATIENT THEN PASSED AWAY SHORTLY THEREAFTER IN THE HOSPITAL FROM MASSIVE BLOOD CLOTS AROUND EVERY LYMPH NODE IN THE BODY
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Fatigue, Feeling abnormal, Headache, Hyperhidrosis
Clinical narrative: Ended up in healthcare facility on 3-1 dehydrated and released Back to healthcare facility on 3-4 stayed until 3-7  Started hallucinating and given meds.  very dehydrated  Released and then family came to pick her up.  Hallucinating on drive back to where she would be staying. 3-8 back to healthcare facility because she was slurring words ---gave fluids and released 3-9 Unit had to come to get her very weak and fragile.  Couldn't move her ourselves. Ended up admitting her until 3-12  At house she was supervised the whole time, weak, needed assistance, slurring words off and on. 3-22 Eye doc appt found blood clot behind eye.  Sent her to healthcare facility to be examined by Neugolist.  Did CT Scan and MRV/MRI found.  They found clots and ended up sending her to healthcare facility.  Was in city where they run tons of tests.  mini strokes lead to the Thrombosis which caused the blood clots.   Released on 4-2 into the care of a home where she started to hallucinate even more.  Back to healthcare facility on 4-9 still currently there where they are treating her hallucinations, memory loss and more.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain, Vomiting, X-ray
Clinical narrative: Ended up in healthcare facility on 3-1 dehydrated and released Back to healthcare facility on 3-4 stayed until 3-7  Started hallucinating and given meds.  very dehydrated  Released and then family came to pick her up.  Hallucinating on drive back to where she would be staying. 3-8 back to healthcare facility because she was slurring words ---gave fluids and released 3-9 Unit had to come to get her very weak and fragile.  Couldn't move her ourselves. Ended up admitting her until 3-12  At house she was supervised the whole time, weak, needed assistance, slurring words off and on. 3-22 Eye doc appt found blood clot behind eye.  Sent her to healthcare facility to be examined by Neugolist.  Did CT Scan and MRV/MRI found.  They found clots and ended up sending her to healthcare facility.  Was in city where they run tons of tests.  mini strokes lead to the Thrombosis which caused the blood clots.   Released on 4-2 into the care of a home where she started to hallucinate even more.  Back to healthcare facility on 4-9 still currently there where they are treating her hallucinations, memory loss and more.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Asthenia, Computerised tomogram, Dehydration, Dysarthria
Clinical narrative: Ended up in healthcare facility on 3-1 dehydrated and released Back to healthcare facility on 3-4 stayed until 3-7  Started hallucinating and given meds.  very dehydrated  Released and then family came to pick her up.  Hallucinating on drive back to where she would be staying. 3-8 back to healthcare facility because she was slurring words ---gave fluids and released 3-9 Unit had to come to get her very weak and fragile.  Couldn't move her ourselves. Ended up admitting her until 3-12  At house she was supervised the whole time, weak, needed assistance, slurring words off and on. 3-22 Eye doc appt found blood clot behind eye.  Sent her to healthcare facility to be examined by Neugolist.  Did CT Scan and MRV/MRI found.  They found clots and ended up sending her to healthcare facility.  Was in city where they run tons of tests.  mini strokes lead to the Thrombosis which caused the blood clots.   Released on 4-2 into the care of a home where she started to hallucinate even more.  Back to healthcare facility on 4-9 still currently there where they are treating her hallucinations, memory loss and more.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hallucination, Magnetic resonance imaging, Mobility decreased, Thrombosis, Transient ischaemic attack
Clinical narrative: Ended up in healthcare facility on 3-1 dehydrated and released Back to healthcare facility on 3-4 stayed until 3-7  Started hallucinating and given meds.  very dehydrated  Released and then family came to pick her up.  Hallucinating on drive back to where she would be staying. 3-8 back to healthcare facility because she was slurring words ---gave fluids and released 3-9 Unit had to come to get her very weak and fragile.  Couldn't move her ourselves. Ended up admitting her until 3-12  At house she was supervised the whole time, weak, needed assistance, slurring words off and on. 3-22 Eye doc appt found blood clot behind eye.  Sent her to healthcare facility to be examined by Neugolist.  Did CT Scan and MRV/MRI found.  They found clots and ended up sending her to healthcare facility.  Was in city where they run tons of tests.  mini strokes lead to the Thrombosis which caused the blood clots.   Released on 4-2 into the care of a home where she started to hallucinate even more.  Back to healthcare facility on 4-9 still currently there where they are treating her hallucinations, memory loss and more.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Venogram
Clinical narrative: Ended up in healthcare facility on 3-1 dehydrated and released Back to healthcare facility on 3-4 stayed until 3-7  Started hallucinating and given meds.  very dehydrated  Released and then family came to pick her up.  Hallucinating on drive back to where she would be staying. 3-8 back to healthcare facility because she was slurring words ---gave fluids and released 3-9 Unit had to come to get her very weak and fragile.  Couldn't move her ourselves. Ended up admitting her until 3-12  At house she was supervised the whole time, weak, needed assistance, slurring words off and on. 3-22 Eye doc appt found blood clot behind eye.  Sent her to healthcare facility to be examined by Neugolist.  Did CT Scan and MRV/MRI found.  They found clots and ended up sending her to healthcare facility.  Was in city where they run tons of tests.  mini strokes lead to the Thrombosis which caused the blood clots.   Released on 4-2 into the care of a home where she started to hallucinate even more.  Back to healthcare facility on 4-9 still currently there where they are treating her hallucinations, memory loss and more.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Cough, Exposure to SARS-CoV-2, SARS-CoV-2 test
Clinical narrative: Caller and husband has been exposed to son.; This is a spontaneous report from contactable consumer (patient). This consumer (patient) reported similar event for 2 patients (herself and her husband). This is 1st of 2 reports. A female patient of an unspecified age received bnt162b2 (Covid-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration on 21Jan2021 as SINGLE DOSE for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient has been exposed to son (exposure to sars-cov-2). She reported that she and her husband received 1st dose of covid vaccine on 21Jan2021. Her son is a Health Care Worker who also received 1st dose of covid vaccine, had tested positive for covid after 1st dose. Caller and husband has been exposed to son. Outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021123343 same product and AE/ different patient
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: Caller and husband has been exposed to son.; This is a spontaneous report from contactable consumer (patient). This consumer (patient) reported similar event for 2 patients (herself and her husband). This is 1st of 2 reports. A female patient of an unspecified age received bnt162b2 (Covid-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration on 21Jan2021 as SINGLE DOSE for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient has been exposed to son (exposure to sars-cov-2). She reported that she and her husband received 1st dose of covid vaccine on 21Jan2021. Her son is a Health Care Worker who also received 1st dose of covid vaccine, had tested positive for covid after 1st dose. Caller and husband has been exposed to son. Outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021123343 same product and AE/ different patient
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Speech disorder, Swollen tongue
Clinical narrative: on feb 21, 4 days after second dose, developed a chronic persistent headache in setting of no prior history of significant headaches. --headache: no change in vision or blindspots; blurry vision noted (just had an eye exam in early February - slight change in prescription), location frontal top of hairline, continuous - every waking minute since Feb 21, has surges of intensity (never crippling, but always there), seems to be worse in evening, able sleep, appetite has been down  -- nothing improves the headache (meds have no effect), no photophobia, no phonophobia, temperature does not impact it
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Decreased appetite, Headache, Vision blurred
Clinical narrative: on feb 21, 4 days after second dose, developed a chronic persistent headache in setting of no prior history of significant headaches. --headache: no change in vision or blindspots; blurry vision noted (just had an eye exam in early February - slight change in prescription), location frontal top of hairline, continuous - every waking minute since Feb 21, has surges of intensity (never crippling, but always there), seems to be worse in evening, able sleep, appetite has been down  -- nothing improves the headache (meds have no effect), no photophobia, no phonophobia, temperature does not impact it
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Headache, Pain in extremity
Clinical narrative: on feb 21, 4 days after second dose, developed a chronic persistent headache in setting of no prior history of significant headaches. --headache: no change in vision or blindspots; blurry vision noted (just had an eye exam in early February - slight change in prescription), location frontal top of hairline, continuous - every waking minute since Feb 21, has surges of intensity (never crippling, but always there), seems to be worse in evening, able sleep, appetite has been down  -- nothing improves the headache (meds have no effect), no photophobia, no phonophobia, temperature does not impact it
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Head injury, Loss of consciousness, Presyncope, Skin abrasion, Tonic clonic movements
Clinical narrative: Vasovagal syncope caused by COVID vaccine causing a fall to the ground and hit head on the floor
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Electrocardiogram, Fall, Head injury, Syncope
Clinical narrative: Vasovagal syncope caused by COVID vaccine causing a fall to the ground and hit head on the floor
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Cardioversion, Intensive care, Resuscitation, Ventricular fibrillation
Clinical narrative: Cardiac Arrest 20min after vaccine administered on site.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain injury, Cardiac arrest
Clinical narrative: Cardiac Arrest 20min after vaccine administered on site.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bleeding time prolonged, Disseminated intravascular coagulation, Mouth haemorrhage, Oral disorder, Platelet count decreased
Clinical narrative: acute thrombocytopenia (down to 6K) not responding to transfusions with mucocutaneous bleeding ~10-12 days after vaccine. Had to be treated with high dose steroids (dexamethasone, prednisone) and IVIG to improve platelet count back to baseline. Baseline normally ~120-170K.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Platelet transfusion, Skin laceration, Thrombocytopenia
Clinical narrative: acute thrombocytopenia (down to 6K) not responding to transfusions with mucocutaneous bleeding ~10-12 days after vaccine. Had to be treated with high dose steroids (dexamethasone, prednisone) and IVIG to improve platelet count back to baseline. Baseline normally ~120-170K.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage, Immunoglobulin therapy, Platelet count decreased, Thrombocytopenia, Transfusion
Clinical narrative: acute thrombocytopenia (down to 6K) not responding to transfusions with mucocutaneous bleeding ~10-12 days after vaccine. Had to be treated with high dose steroids (dexamethasone, prednisone) and IVIG to improve platelet count back to baseline. Baseline normally ~120-170K.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Aphasia, Immediate post-injection reaction
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: ADAMTS13 activity decreased, Arteriosclerosis, Cerebral ischaemia, Haemoglobin decreased, Magnetic resonance imaging head abnormal
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Plasmapheresis, Platelet count decreased, Thrombocytopenia, Thrombotic thrombocytopenic purpura, Transient ischaemic attack
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: White blood cell count normal
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Neurological symptom, Plasmapheresis, Platelet count decreased, Thrombotic thrombocytopenic purpura, Transient ischaemic attack
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: ADAMTS13 activity abnormal, Arteriosclerosis, Cerebral ischaemia, Computerised tomogram head abnormal, Hypoaesthesia
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Platelet count decreased, Speech disorder, Thrombocytopenia, Thrombotic thrombocytopenic purpura
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: My father received the first dose of the moderna vaccine on February 21, 2021. On March 19, 2021 my father exhibited stroke-like symptoms and was admitted into the hospital for a medical emergency. The doctors ran multiple tests and determined that he suffered a transient ischemic attack (TIA). His symptoms subsided and he was discharged on March 20, 2021. He received his second dose of the moderna vaccine on March 21, 2021 and, on the same day, suffered the same stroke-like symptoms which the doctors determined was another TIA. My father had no previous history of strokes, seizures or stroke-like symptoms prior to receiving the moderna vaccine. My father was re-admitted into the hospital on March 21, 2021 and over the course of two weeks was subject to a number of tests which revealed that his platelet count had significantly decreased to the point where his blood began to clot. They diagnosed him with a sudden onset of thrombotic thrombocytopenic purpura (TTP). The doctors explained that TTP was very serious and life-threatening disease if left untreated. Since this discovery, my father has needed to receive multiple plasma exchanges and rituximab treatments. I have written records asking the doctors about the link between the moderna vaccine and his TTP. The doctors recommended that I report this information. I believe it's critical for others to be made aware about the serious side effects of the moderna vaccine. I am willing to share my father's medical records which proves the drastic decrease in his platelet count following his receiving the moderna vaccine.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Full blood count normal, Lip swelling, Metabolic function test normal, Swollen tongue
Clinical narrative: ANGIOEDEMA; This spontaneous report received from a pharmacist concerned an 81 year old female patient. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 25-MAR-2021 (1 hour after vaccination), the patient developed angioedema and was hospitalized. She did not experience respiratory distress. The patient was discharged on 31-MAR-2021. The number of days of hospitalization was 6. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from angioedema on 31-MAR-2021. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210408678-covid-19 vaccine ad26.cov2.s - Angioedema. This event is considered related. The event has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA; This spontaneous report received from a pharmacist concerned an 81 year old female patient. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 25-MAR-2021 (1 hour after vaccination), the patient developed angioedema and was hospitalized. She did not experience respiratory distress. The patient was discharged on 31-MAR-2021. The number of days of hospitalization was 6. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from angioedema on 31-MAR-2021. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210408678-covid-19 vaccine ad26.cov2.s - Angioedema. This event is considered related. The event has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Patient said that she had swollen lymph nodes in her left armpit starting 7 days after her first dose. She said they were the size of a golf ball and  were painful. Patient said it lasted for 2 weeks.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Patient said that she had swollen lymph nodes in her left armpit starting 7 days after her first dose. She said they were the size of a golf ball and  were painful. Patient said it lasted for 2 weeks.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoaesthesia, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: BELL'S PALSY; NUMBNESS IN ARMS, LEGS, LOWER ABDOMEN AND BUTTLOCKS; ITCHING THROUGHOUT; TINGLING IN ARM, LEGS, FEET AND HAND; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight was 240 (unit unspecified), and height was 182.88 centimeters. The patient's concurrent conditions included hypertension, and other pre-existing medical conditions included patient had family history of any disease (relevant to vaccination) or allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the patient experienced bell's palsy, numbness in arms, legs, lower abdomen and buttlocks, itching throughout, tingling in arm, legs, feet and hand. Laboratory data (dates unspecified) included: Blood test (NR: not provided) nothing out of range, CT scan (NR: not provided) negative, Chest X-ray (NR: not provided) negative, and Urinalysis (NR: not provided) nothing out of range. Treatment medications (dates unspecified) included: hydrochlorothiazide/lisinopril. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itching throughout on 23-MAR-2021, was recovering from numbness in arms, legs, lower abdomen and buttlocks, and tingling in arm, legs, feet and hand and bell's palsy. This report was serious (Other Medically Important Condition).  Additional information was received from patient on 31/03/2021. The following information was updated and incorporated into the case narrative: Reporter (HCP), Patient demographics (Gender, weight, height, Concomitant condition), Event (Bell's Palsy), Lab Test : CT Scan (Head and Torso), Blood work, Urinalysis, Chest X-ray- negative, Suspect product: (Route of administration), drug used to treat AE (Lisinopril) was added.; Sender's Comments: V1: Additional information received in this version is regarding patient demographics, serious event Bell's palsy, lab test, medical history of the patient. This information changes the seriousness of the case from V0 nonserious to V1 serious.  20210357779-Covid-19 vaccine ad26.cov2.s-Bell's palsy. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).